Cyclic vomiting syndrome: A case series and review of the literature

Frontline Gastroenterology

Volumn 9, Issue 1, 2018, Pages 2-9

  Shearer, Jessica ^a   Luthra, Pavit ^a   Ford, Alexander C ^a,b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; AMYLASE; CANNABIS; MITOCHONDRIAL DNA;

ADULT; AGE; CANNABIS ADDICTION; CANNABIS USE; CASE STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; CYCLIC VOMITING SYNDROME; DIFFERENTIAL DIAGNOSIS; DRUG DOSE TITRATION; FEMALE; HUMAN; MALE; MAXIMUM TOLERATED DOSE; MEDICAL RECORD REVIEW; NAUSEA AND VOMITING; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RETROSPECTIVE STUDY; REVIEW; SEX; SYMPTOM; SYNDROME; TREATMENT RESPONSE; VOMITING; YOUNG ADULT;

EID: 85041710781     PISSN: 20414137     EISSN: 20414145     Source Type: Journal    
DOI: 10.1136/flgastro-2016-100705     Document Type: Review

References (65)

1. Camilleri M, Dubois D, Coulie B, et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: Results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol 2005;3:543-52.
2. Hoyt CS, Stickler GB. A study of 44 children with the syndrome of recurrent (cyclic) vomiting. Pediatrics 1960;25:775-80.
3. Fitzpatrick E, Bourke B, Drumm B, et al. The incidence of cyclic vomiting syndrome in children: Population-based study. Am J Gastroenterol 2008;103:991-5; quiz 996.
4. Abu-Arafeh I, Russell G. Cyclical vomiting syndrome in children: a population-based study. J Pediatr Gastroenterol Nutr 1995;21:454-8.
5. Abell TL, Kim CH, Malagelada JR. Idiopathic cyclic nausea and vomiting-a disorder of gastrointestinal motility? Mayo Clin Proc 1988;63:1169-75.
6. Allen JH, de Moore GM, Heddle R, et al. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut 2004;53:1566-70.
7. Taché Y. Cyclic vomiting syndrome: The corticotropin-releasingfactor hypothesis. Dig Dis Sci 1999;44 (8 Suppl):79s-86s.
8. Venkatesan T, Prieto T, Barboi A, et al. Autonomic nerve function in adults with cyclic vomiting syndrome: a prospective study. Neurogastroenterol Motil 2010;22: 1303-7, e339.
9. Rashed H, Abell TL, Familoni BO, et al. Autonomic function in cyclic vomiting syndrome and classic migraine. Dig Dis Sci 1999;44(8 Suppl):74s-8s.
10. Venkatesan T, Tarbell S, Adams K, et al. A survey of emergency department use in patients with cyclic vomiting syndrome. BMC Emerg Med 2010;10:4.
11. Prakash C, Staiano A, Rothbaum RJ, et al. Similarities in cyclic vomiting syndrome across age groups. Am J Gastroenterol 2001;96:684-8.
12. Lee LY, Abbott L, Mahlangu B, et al. The management of cyclic vomiting syndrome: a systematic review. Eur J Gastroenterol Hepatol 2012;24:1001-6.
13. Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-79.
14. Hejazi RA, Patil H, McCallum RW. Dumping syndrome: establishing criteria for diagnosis and identifying new etiologies. Dig Dis Sci 2010;55:117-23.
15. Namin F, Patel J, Lin Z, et al. Clinical, psychiatric and manometric profile of cyclic vomiting syndrome in adults and response to tricyclic therapy. Neurogastroenterol Motil 2007;19:196-202.
16. Devanarayana NM, Adhikari C, Pannala W, et al. Prevalence of functional gastrointestinal diseases in a cohort of Sri Lankan adolescents: comparison between Rome II and Rome III criteria. J Trop Pediatr 2011;57:34-9.
17. Hejazi RA, McCallum RW. Review article: Cyclic vomiting syndrome in adults-rediscovering and redefining an old entity. Aliment Pharmacol Ther 2011;34:263-73.
18. Fleisher DR, Gornowicz B, Adams K, et al. Cyclic vomiting syndrome in 41 adults: the illness, the patients, and problems of management. BMC Med 2005;3:20.
19. Hejazi RA, Lavenbarg TH, McCallum RW. Spectrum of gastric emptying patterns in adult patients with cyclic vomiting syndrome. Neurogastroenterol Motil 2010;22:1298-302, e338.
20. Sharkey KA, Darmani NA, Parker LA. Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system. Eur J Pharmacol 2014;722:134-46.
21. Sontineni SP, Chaudhary S, Sontineni V, et al. Cannabinoid hyperemesis syndrome: Clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse. World J Gastroenterol 2009;15:1264-6.
22. Iacopetti CL, Packer CD. Cannabinoid hyperemesis syndrome: a case report and review of pathophysiology. Clin Med Res 2014;12:65-7.
23. Chepyala P, Olden KW. Cyclic vomiting and compulsive bathing with chronic cannabis abuse. Clin Gastroenterol Hepatol 2008;6:710-12.
24. Ruffle JK, Bajgoric S, Samra K, et al. Cannabinoid hyperemesis syndrome: an important differential diagnosis of persistent unexplained vomiting. Eur J Gastroenterol Hepatol 2015;27:1403-8.
25. Simonetto DA, Oxentenko AS, Herman ML, et al. Cannabinoid hyperemesis: a case series of 98 patients. Mayo Clin Proc 2012;87:114-19.
26. Venkatesan T, Sengupta J, Lodhi A, et al. An Internet survey of marijuana and hot shower use in adults with cyclic vomiting syndrome (CVS). Exp Brain Res 2014;232:2563-70.
27. Stout SC, Owens MJ, Nemeroff CB. Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment. J Pharmacol Exp Ther 2002;300:1085-92.
28. Basta-Kaim A, Budziszewska B, Jaworska-Feil L, et al. Inhibitory effect of imipramine on the human corticotropin-releasing-hormone gene promoter activity operates through a PI3-K/AKT mediated pathway. Neuropharmacology 2005;49:156-64.
29. Hejazi RA, Lavenbarg TH, Pasnoor M, et al. Autonomic nerve function in adult patients with cyclic vomiting syndrome. Neurogastroenterol Motil 2011;23:439-43.
30. Cooper CJ, Said S, Bizet J, et al. Rapid or normal gastric emptying as new supportive criteria for diagnosing cyclic vomiting syndrome in adults. Med Sci Monit 2014;20:1491-5.
31. Christensen CJ, Johnson WD, Abell TL. Patients with cyclic vomiting pattern and diabetic gastropathy have more migraines, abnormal electrogastrograms, and gastric emptying. Scand J Gastroenterol 2008;43:1076-81.
32. Hejazi RA, Reddymasu SC, Namin F, et al. Efficacy of tricyclic antidepressant therapy in adults with cyclic vomiting syndrome: a two-year follow-up study. J Clin Gastroenterol 2010;44:18-21.
33. Prakash C, Clouse RE. Cyclic vomiting syndrome in adults: clinical features and response to tricyclic antidepressants. Am J Gastroenterol 1999;94:2855-60.
34. Hikita T, Kodama H, Kaneko S, et al. Sumatriptan as a treatment for cyclic vomiting syndrome: a clinical trial. Cephalalgia 2011;31:504-7.
35. Kowalczyk M, Parkman H, Ward L. Adult cyclic vomiting syndrome successfully treated with intranasal sumatriptan. J Gen Intern Med 2010;25:88-91.
36. Boles RG, Adams K, Li BU. Maternal inheritance in cyclic vomiting syndrome. Am J Med Genet A 2005;133A:71-7.
37. Boles RG, Zaki EA, Lavenbarg T, et al. Are pediatric and adult-onset cyclic vomiting syndrome (CVS) biologically different conditions? Relationship of adult-onset CVS with the migraine and pediatric CVS-associated common mtDNA polymorphisms 16519Tand 3010A. Neurogastroenterol Motil 2009;21:936-e72.
38. Zaki EA, Freilinger T, Klopstock T, et al. Two common mitochondrial DNA polymorphisms are highly associated with migraine headache and cyclic vomiting syndrome. Cephalalgia 2009;29:719-28.
39. Venkatesan T, Zaki EA, Kumar N, et al. Quantitative pedigree analysis and mitochondrial DNA sequence variants in adults with cyclic vomiting syndrome. BMC Gastroenterol 2014;14:181.
40. Lee J, Wong SA, Li BU, et al. NextGen nuclear DNA sequencing in cyclic vomiting syndrome reveals a significant association with the stress-induced calcium channel (RYR2). Neurogastroenterol Motil 2015;27:990-6.
41. Galli JA, Sawaya RA, Friedenberg FK. Cannabinoid hyperemesis syndrome. Curr Drug Abuse Rev 2011;4:241-9.
42. Gunasekaran N, Long LE, Dawson BL, et al. Reintoxication: the release of fat-stored delta(9)-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure. Br J Pharmacol 2009;158:1330-7.
43. Chang YH, Windish DM. Cannabinoid hyperemesis relieved by compulsive bathing. Mayo Clin Proc 2009;84:76-8.
44. Izzo AA, Camilleri M. Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. Gut 2008;57:1140-55.
45. McCallum RW, Soykan I, Sridhar KR, et al. Delta-9- tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study. Aliment Pharmacol Ther 1999;13:77-80.
46. Iversen L. Cannabis and the brain. Brain 2003;126:1252-70.
47. Abell TL, Adams KA, Boles RG, et al. Cyclic vomiting syndrome in adults. Neurogastroenterol Motil 2008;20:269-84.
48. Li BU, Murray RD, Heitlinger LA, et al. Heterogeneity of diagnoses presenting as cyclic vomiting. Pediatrics 1998;102:583-7.
49. Okumura T, Ohhira M, Kumei S, et al. An adult patient with cyclic vomiting syndrome successfully treated with oral sumatriptan. Am J Gastroenterol 2014;109:292-3.
50. Chepyala P, Svoboda RP, Olden KW. Treatment of cyclic vomiting syndrome. Curr Treat Options Gastroenterol 2007;10:273-82.
51. Saligram S, Bielefeldt K. The two sides of opioids in cyclical vomiting syndrome. N Am J Med Sci 2014;6:114-18.
52. Tarbell SE, Li BU. Health-related quality of life in children and adolescents with cyclic vomiting syndrome: a comparison with published data on youth with irritable bowel syndrome and organic gastrointestinal disorders. J Pediatr 2013;163:493-7.
53. Hejazi RA, Lavenbarg TH, Foran P, et al. Who are the nonresponders to standard treatment with tricyclic antidepressant agents for cyclic vomiting syndrome in adults? Aliment Pharmacol Ther 2010;31:295-301.
54. Clouse RE, Sayuk GS, Lustman PJ, et al. Zonisamide or levetiracetam for adults with cyclic vomiting syndrome: a case series. Clin Gastroenterol Hepatol 2007;5:44-8.
55. Boles RG. High degree of efficacy in the treatment of cyclic vomiting syndrome with combined co-enzyme Q10, L-carnitine and amitriptyline, a case series. BMC Neurol 2011;11:102.
56. Boles RG, Lovett-Barr MR, Preston A, et al. Treatment of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective study. BMC Neurol 2010;10:10.
57. Weitz R. Prophylaxis of cyclic vomiting with propranolol. Drug Intell Clin Pharm 1982;16:161-2.
58. Haghighat M, Dehghani SM, Shahramian I, et al. Combination of erythromycin and propranolol for treatment of childhood cyclic vomiting syndrome: a novel regimen. Gastroenterol Hepatol Bed Bench 2015;8:270-7.
59. Andersen JM, Sugerman KS, Lockhart JR, et al. Effective prophylactic therapy for cyclic vomiting syndrome in children using amitriptyline or cyproheptadine. Pediatrics 1997;100:977-81.
60. Cristofori F, Thapar N, Saliakellis E, et al. Efficacy of the neurokinin-1 receptor antagonist aprepitant in children with cyclical vomiting syndrome. Aliment Pharmacol Ther 2014;40:309-17.
61. Hayes WJ, Weisensee LA, Kappes JA, et al. OnabotulinumtoxinA injections for the treatment of cyclic vomiting syndrome. Pharmacotherapy 2015;35: e51-5.
62. Vidula MK, Wadhwani A, Roberts K, et al. Use of a once-daily NSAID in treatment of cyclic vomiting syndrome. J Gen Intern Med 2014;29:543-6.
63. Nakazato Y, Tamura N, Shimazu K. An adult case of cyclic vomiting syndrome successfully responding to valproic acid. J Neurol 2008;255:934-5.
64. Ford AC, Forman D, Bailey AG, et al. Initial poor quality of life and new onset of dyspepsia: Results from a longitudinal 10-year follow-up study. Gut 2007;56:321-7.
65. Ford AC, Forman D, Bailey AG, et al. Irritable bowel syndrome: a 10-year natural history of symptoms, and factors that influence consultation behavior. Am J Gastroenterol 2008;103:1229-39.